Cryo Cell International (CCEL) Operating Expenses (2010 - 2026)

Cryo Cell International has disclosed Operating Expenses across 17 years of filings, most recently posting $6.9 million for Q1 2026.

• In Q1 2026, Operating Expenses changed 0.07% year-over-year to $6.9 million; the TTM figure through Feb 2026 stood at $31.1 million (up 9.52% YoY), while the FY2025 annual figure was $31.1 million, up 9.04% from the prior year.
• Operating Expenses slipped to $6.9 million in Q1 2026, from $11.8 million in the prior quarter.
• Over the last five years, Operating Expenses for CCEL reached as high as $24.1 million in Q4 2023 and fell as low as $5.8 million in Q1 2022.
• The 5-year median for Operating Expenses is $6.7 million (2022), against an average of $8.0 million.
• Annual changes were most pronounced in 2023 — Operating Expenses soared 226.86% — and 2024, when it tumbled 66.13%.
• A 5-year view of Operating Expenses shows it stood at $7.4 million in 2022, then soared by 226.86% to $24.1 million in 2023, then slumped by 66.13% to $8.1 million in 2024, then surged by 44.97% to $11.8 million in 2025, then sank by 41.42% to $6.9 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $6.9 million, $11.8 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.